semaglutide oral fda FDA-Approved Semaglutide: The First GLP-1 Pill FDA Approves Novo Nordisk's Oral

Gallbladder events rise modestly, especially with rapid loss. Less common signals include skin dysesthesia, which is now on the label, and a small thyroid-cancer association from two different instruments: a nested case-control study and an RCT meta-analysis, both on a small absolute event base. Depression and suicidality remain unproven

It's like- Andrew Huberman: It's slow acting

Read the study here

In practice, pharmaceutical firms are investing a lot, not only for new therapies but for next-gen approaches, along with refined formulations and even wider use across different patient groups

And our associate producer is Sarah Kaplan